Results 91 to 100 of about 26,051 (185)
Background: Amyloid light chain (AL) amyloidosis is an uncommon multisystem condition. We report a globally unique case of a patient with AL amyloidosis affecting the heart and temporal arteries.
Ameer Rashed, MBBS, BSc +5 more
doaj +1 more source
Early‐Onset Wild‐Type Transthyretin Amyloidosis Polyneuropathy
Muscle &Nerve, Volume 74, Issue 5, Page 1471-1475, November 2026.
Chafic Karam +7 more
wiley +1 more source
Amyloidosis is characterized by the tissue deposition of insoluble fibrils derived from misfolded proteins. This case report describes a Hispanic man diagnosed with both monoclonal gammopathy of undetermined significance (MGUS) and wild-type ...
Amalia Peix +9 more
doaj +1 more source
Tiffany P Quock,1 Tingjian Yan,2 Ryan Tieu,2 Anita D’Souza,3 Michael S Broder21Medical Affairs, Prothena Biosciences Inc, South San Francisco, CA, USA; 2Health Services Research, Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA;
Quock TP +4 more
doaj
Introduction: Systemic amyloidosis is a condition where amyloid proteins accumulate in organs and tissues, causing multisystem dysfunction. Its presentation often overlaps with other conditions like lymphoproliferative disorders and multiple myeloma (MM).
Naciye Nur Tozluklu +3 more
doaj +1 more source
Myocardial Perfusion in Cardiac Amyloidosis
Abstract Aims Cardiac involvement is the main driver of clinical outcomes in systemic amyloidosis and preliminary studies support the hypothesis that myocardial ischaemia contributes to cellular damage.
Chacko, Liza +29 more
openaire +4 more sources
Cardiac amyloidosis in a Swiss autopsy cohort – distribution and clinical relevance
AIMS: Cardiac amyloidosis (CA) characterised by myocardial amyloid accumulation is likely underdiagnosed. The distribution and extent of myocardial amyloid deposits remain unclear.
Albert Baschong +7 more
doaj +1 more source
Cardiac Amyloidosis in a Horse [PDF]
Yvette S, Nout +4 more
openaire +2 more sources

